Table 1.

Characteristics of study population.

	N	Median (Range)
Age in years	66	51 (23–90)
Survival (months)		16 (2–88)
	N	Percent
Gender
Female	21	32%
Male	45	68%
Response
Responder	18	27%
Non responder	48	73%
Types of chemotherapy
Single agent TMZ	29	44%
TMZ-based combination	3	5%
Single agent DTIC	16	24%
DTIC-based combination	18	27%